|
1
|
Oya M and Kikuchi E; Committee for
Establishment of Clinical Practice Guideline for Management of
Upper Tract Urothelial Carcinoma; Japanese Urological Association,
: Evidenced-based clinical practice guideline for upper tract
urothelial carcinoma (summary-Japanese Urological Association, 2014
edition). Int J Urol. 22:3–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rouprêt M, Babjuk M, Compérat E, Zigeuner
R, Sylvester RJ, Burger M, Cowan NC, Böhle A, Van Rhijn BWG,
Kaasinen E, et al: European Association of Urology Guidelines on
Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur
Urol. 68:868–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ministry of Health, Labour and Welfare, .
Vital Statistics of Japan (Volume 1~3), General Mortality.
https://www.mhlw.go.jp/english/database/db-hw/vs01.htmlSeptember
7–2018
|
|
5
|
Margulis V, Shariat SF, Matin SF, Kamat
AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD and Wood CG:
Upper tract urothelial carcinoma collaboration the upper tract
urothelial carcinoma collaboration: outcomes of radical
nephroureterectomy: A series from the upper tract urothelial
carcinoma collaboration. Cancer. 115:1224–1233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Witjes JA, Compérat E, Cowan NC, De Santis
M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG and Sherif A;
European Association of Urology, : EAU guidelines on
muscle-invasive and metastatic bladder cancer: Summary of the 2013
guidelines. Eur Urol. 65:778–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rink M, Sjoberg D, Comploj E, Margulis V,
Xylinas E, Lee RK, Hansen J, Cha EK, Raman JD, Remzi M, et al: Risk
of cancer-specific mortality following recurrence after radical
nephroureterectomy. Ann Surg Oncol. 19:4337–4344. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leow JJ, Orsola A, Chang SL and Bellmunt
J: A contemporary review of management and prognostic factors of
upper tract urothelial carcinoma. Cancer Treat Rev. 41:310–319.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guthrie GJ, Charles KA, Roxburgh CS,
Horgan PG, McMillan DC and Clarke SJ: The systemic
inflammation-based neutrophil-lymphocyte ratio: Experience in
patients with cancer. Crit Rev Oncol Hematol. 88:218–230. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Viers BR, Boorjian SA, Frank I, Tarrell
RF, Thapa P, Karnes RJ, Thompson RH and Tollefson MK: Pretreatment
neutrophil-to-lymphocyte ratio is associated with advanced
pathologic tumor stage and increased cancer-specific mortality
among patients with urothelial carcinoma of the bladder undergoing
radical cystectomy. Eur Urol. 66:1157–1164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gondo T, Nakashima J, Ohno Y, Choichiro O,
Horiguchi Y, Namiki K, Yoshioka K, Ohori M, Hatano T and Tachibana
M: Prognostic value of neutrophil-to-lymphocyte ratio and
establishment of novel preoperative risk stratification model in
bladder cancer patients treated with radical cystectomy. Urology.
79:1085–1091. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krane LS, Richards KA, Kader AK, Davis R,
Balaji KC and Hemal AK: Preoperative neutrophil/lymphocyte ratio
predicts overall survival and extravesical disease in patients
undergoing radical cystectomy. J Endourol. 27:1046–1050. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tanaka N, Kikuchi E, Kanao K, Matsumoto K,
Shirotake S, Miyazaki Y, Kobayashi H, Kaneko G, Hagiwara M, Ide H,
et al: A multi-institutional validation of the prognostic value of
the neutrophil-to-lymphocyte ratio for upper tract urothelial
carcinoma treated with radical nephroureterectomy. Ann Surg Oncol.
21:4041–4048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dalpiaz O, Ehrlich GC, Mannweiler S,
Hernández JM, Gerger A, Stojakovic T, Pummer K, Zigeuner R, Pichler
M and Hutterer GC: Validation of pretreatment neutrophil-lymphocyte
ratio as a prognostic factor in a European cohort of patients with
upper tract urothelial carcinoma. BJU Int. 114:334–339.
2014.PubMed/NCBI
|
|
16
|
Sobin LH, Gospodarowicz MK and Wittekind
C: UICC TNM Classification of Malignant Tumours (7th edition).
Wiley-Blackwell. New Jersey, NY: 2009.
|
|
17
|
Mostofi FK, Davis CJ and Sesterhenn IA:
World Health Organization International Histological Classification
of Tumours. Histological typing of urinary bladder tumours (2nd
edition). Springer-Verlag Berlin. Heidelberg: 1999. View Article : Google Scholar
|
|
18
|
Azuma T, Matayoshi Y, Odani K, Sato Y,
Sato Y, Nagase Y and Oshi M: Preoperative neutrophil-lymphocyte
ratio as an independent prognostic marker for patients with upper
urinary tract urothelial carcinoma. Clin Genitourin Cancer.
11:337–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Advanced Bladder Cancer (ABC)
Meta-analysis Collaboration, . Neoadjuvant chemotherapy in invasive
bladder cancer: Update of a systematic review and meta-analysis of
individual patient data advanced bladder cancer (ABC) meta-analysis
collaboration. Eur Urol. 48:202–205; discussion 205–206. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fritz GA, Schoellnast H, Deutschmann HA,
Quehenberger F and Tillich M: Multiphasic multidetector-row CT
(MDCT) in detection and staging of transitional cell carcinomas of
the upper urinary tract. Eur Radiol. 16:1244–1252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kang M, Jeong CW, Kwak C, Kim HH and Ku
JH: The prognostic significance of the early postoperative
neutrophil-to-lymphocyte ratio in patients with urothelial
carcinoma of the bladder undergoing radical cystectomy. Ann Surg
Oncol. 23:335–342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morizawa Y, Miyake M, Shimada K, Hori S,
Tatsumi Y, Nakai Y, Anai S, Tanaka N, Konishi N and Fujimoto K:
Neutrophil-to-lymphocyte ratio as a detection marker of tumor
recurrence in patients with muscle-invasive bladder cancer after
radical cystectomy. Urol Oncol. 34(257): e211–257.
2016.doi.org/10.1016/j.urolonc.2016.02.012.
|
|
23
|
Tanaka H, Tamura T, Toyokawa T, Muguruma
K, Miki Y, Kubo N, Sakurai K, Hirakawa K and Ohira M: Clinical
relevance of postoperative neutrophil-lymphocyte ratio (NLR) to
recurrence after adjuvant chemotherapy of S-1 for gastric cancer.
Anticancer Res. 38:3745–3751. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin F, Han A, Shi F, Kong L and Yu J: The
postoperative neutrophil-to-lymphocyte ratio and changes in this
ratio predict survival after the complete resection of stage I
non-small cell lung cancer. OncoTargets Ther. 9:6529–6537. 2016.
View Article : Google Scholar
|
|
25
|
Birtle AJ, Chester JD, Jones RJ, Johnson
M, Hill M, Bryan RT, Catto J, Donovan J, French A, Harris C, et al:
Results of POUT: A phase III randomised trial of perioperative
chemotherapy versus surveillance in upper tract urothelial cancer
(UTUC). J Clin Oncol. 36 (6_suppl):407. 2018. View Article : Google Scholar
|
|
26
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gooden MJ, de Bock GH, Leffers N, Daemen T
and Nijman HW: The prognostic influence of tumour-infiltrating
lymphocytes in cancer: A systematic review with meta-analysis. Br J
Cancer. 105:93–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fogar P, Sperti C, Basso D, Sanzari MC,
Greco E, Davoli C, Navaglia F, Zambon CF, Pasquali C, Venza E, et
al: Decreased total lymphocyte counts in pancreatic cancer: An
index of adverse outcome. Pancreas. 32:22–28. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saroha S, Uzzo RG, Plimack ER, Ruth K and
Al-Saleem T: Lymphopenia is an independent predictor of inferior
outcome in clear cell renal carcinoma. J Urol. 189:454–461. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Glaser R and Kiecolt-Glaser JK:
Stress-induced immune dysfunction: Implications for health. Nat Rev
Immunol. 5:243–251. 2005. View
Article : Google Scholar : PubMed/NCBI
|
